Rhegen
Shenzhen
About Rhegen
Rhegen is a research and development of mRNA medicine and gene therapy. The business creates the platform technologies needed for nucleic acid therapeutics, such as mRNA design and synthesis and non-carrier delivery, and applies these technologies to the field of drug research and development with market potential and clinical value.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $14.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2023)
- Website: rhegen.com
- Phone: 0755-3329-1915
Industries & Categories
Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/rhegen-85152 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.